Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Histogen News

    0,50 $ 0,00% +0,00 $
    In : 0,4710 € | 18.04.24 20:42:04 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3DMJS
    ISIN: US43358Y2028
    US-Symbol: HSTO
    Typ: Aktie

    Histogen News

    12.07.22 - PR Newswire
    Thinking about buying stock in Histogen, Canoo, Aldeyra Therapeutics, Target Hospitality, or Redbox Entertainment?
    Thinking about buying stock in Histogen, Canoo, Aldeyra Therapeutics, Target Hospitality, or Redbox Entertainment? PR Newswire
    23.03.22 - PR Newswire
    Thinking about buying stock in AMC Entertainment, Mullen Automotive, DiDi Global, Exela Technologies, or Histogen?
    Thinking about buying stock in AMC Entertainment, Mullen Automotive, DiDi Global, Exela Technologies, or Histogen? PR Newswire
    22.06.21 - PR Newswire
    Thinking about buying stock in Biocept, Histogen, Idera Pharmaceuticals, Satsuma Pharmaceuticals, or Clover Health Investments?
    Thinking about buying stock in Biocept, Histogen, Idera Pharmaceuticals, Satsuma Pharmaceuticals, or Clover Health Investments? PR Newswire
    07.01.21 - PR Newswire
    DLA Piper advises Histogen in its US$14 million upsized public offering
    DLA Piper advises Histogen in its US$14 million upsized public offering PR Newswire
    06.02.20 - PR Newswire
    Histogen to Present at BIO CEO & Investor Conference
    Histogen to Present at BIO CEO & Investor Conference PR Newswire
    30.01.20 - PR Newswire
    Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership
    Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership Allergan Granted Exclusive Rights to Market Histogen's CCM in Dermabrasion Therapies PR ...
    29.08.16 - PR Newswire
    Exalenz Bioscience Announces Collaboration with Conatus Pharmaceuticals to Use BreathID® to Monitor Patients with Cirrhosis Associated with NASH
    Exalenz Bioscience Announces Collaboration with Conatus Pharmaceuticals to Use BreathID® to Monitor Patients with Cirrhosis Associated with NASH Company's non-​invasive ...
    29.08.16 - PR Newswire
    Exalenz Bioscience Announces Collaboration with Conatus Pharmaceuticals to Use BreathID® to Monitor Patients with Cirrhosis Associated with NASH
    Exalenz Bioscience Announces Collaboration with Conatus Pharmaceuticals to Use BreathID® to Monitor Patients with Cirrhosis Associated with NASH Company's non-​invasive ...

    Newssuche

    Videos

    newspaper
    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »